Evidence map›Paper›PMID 36254680›Full record

ArticleProtein science : a publication of the Protein Society2022

Probing the origin of prion protein misfolding via reconstruction of ancestral proteins.

Leonardo M Cortez, Anneliese J Morrison, Craig R Garen, Sawyer Patterson, Toshi Uyesugi, Rafayel Petrosyan, Rohith Vedhthaanth Sekar, Michael J Harms, Michael T Woodside, Valerie L Sim

Open access · bronzeAbstract read
In one paragraph

Article in Protein science : a publication of the Protein Society, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Probing the origin of prion protein misfolding via reconstruction of ancestral proteins.Protein science : a publication of the Protein Society · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Leonardo M CortezCentre for Prions and Protein Folding Diseases, University of Alberta, Edmonton, Alberta, Canada.
Anneliese J MorrisonInstitute of Molecular Biology, University of Oregon, Eugene, Oregon, USA.
Craig R GarenDepartment of Physics, University of Alberta, Edmonton, Alberta, Canada.
Sawyer PattersonCentre for Prions and Protein Folding Diseases, University of Alberta, Edmonton, Alberta, Canada.
Toshi UyesugiDepartment of Physics, University of Alberta, Edmonton, Alberta, Canada.
Rafayel PetrosyanDepartment of Physics, University of Alberta, Edmonton, Alberta, Canada.
Rohith Vedhthaanth SekarDepartment of Physics, University of Alberta, Edmonton, Alberta, Canada.
Michael J HarmsInstitute of Molecular Biology, University of Oregon, Eugene, Oregon, USA.ORCID 0000-0002-0241-4122
Michael T WoodsideCentre for Prions and Protein Folding Diseases, University of Alberta, Edmonton, Alberta, Canada.ORCID 0000-0003-4695-0397
Valerie L SimCentre for Prions and Protein Folding Diseases, University of Alberta, Edmonton, Alberta, Canada.ORCID 0000-0002-0088-8666
University of Alberta · CAUniversity of Oregon · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prion diseases are fatal neurodegenerative diseases caused by pathogenic misfolding of the prion protein, PrP. They are transmissible between hosts, and sometimes between different species, as with transmission of bovine spongiform encephalopathy to humans. Although PrP is found in a wide range of vertebrates, prion diseases are seen only in certain mammals, suggesting that infectious misfolding was a recent evolutionary development. To explore when PrP acquired the ability to misfold infectiously, we reconstructed the sequences of ancestral versions of PrP from the last common primate, primate-rodent, artiodactyl, placental, bird, and amniote. Recombinant ancestral PrPs were then tested for their ability to form β-sheet aggregates, either spontaneously or when seeded with infectious prion strains from human, cervid, or rodent species. The ability to aggregate developed after the oldest ancestor (last common amniote), and aggregation capabilities diverged along evolutionary pathways consistent with modern-day susceptibilities. Ancestral bird PrP could not be seeded with modern-day prions, just as modern-day birds are resistant to prion disease. Computational modeling of structures suggested that differences in helix 2 could account for the resistance of ancestral bird PrP to seeding. Interestingly, ancestral primate PrP could be converted by all prion seeds, including both human and cervid prions, raising the possibility that species descended from an ancestral primate have retained the susceptibility to conversion by cervid prions. More generally, the results suggest that susceptibility to prion disease emerged prior to ~100 million years ago, with placental mammals possibly being generally susceptible to disease.

Indexed as

Prion DiseasesPrionsAnimalsCattleFemaleHumansMammalsPlacentaPregnancyPrion ProteinsPrion ProteinsPrionsancestral sequence reconstructionprion proteinprotein aggregationseedingstructural modeling

Identifiers

PMID36254680
PMCPMC9667828
OpenAlexW4306684758

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.